Merck KGaA to acquire Bio-Techne for $11.3 Billion in major life sciences deal
Acquisition strengthens Merck's life sciences portfolio, expands capabilities across research and biopharma manufacturing
Acquisition strengthens Merck's life sciences portfolio, expands capabilities across research and biopharma manufacturing
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
Unified digital platform enables medicine price verification and grievance redressal in one place
The amendments notified under the Clinical Establishments Act, 2010 form part of this broader reform initiative aimed at creating a more responsive and facilitative regulatory ecosystem
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
National conference brings together 160+ experts from six states to advance blood quality and safety standards
His expertise spans supply chain management, strategic planning, operational transformation, and cross-functional leadership
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
Subscribe To Our Newsletter & Stay Updated